Search

Misook Yu

Supervisory Patent Examiner (ID: 17396, Phone: (571)272-0839 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1641, 1642
Total Applications
873
Issued Applications
267
Pending Applications
202
Abandoned Applications
406

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 72178 [patent_doc_number] => 07754857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Human p51 genes and gene products thereof' [patent_app_type] => utility [patent_app_number] => 12/169213 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26346 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754857.pdf [firstpage_image] =>[orig_patent_app_number] => 12169213 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/169213
Human p51 genes and gene products thereof Jul 7, 2008 Issued
Array ( [id] => 6499630 [patent_doc_number] => 20100215615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/452264 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5262 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215615.pdf [firstpage_image] =>[orig_patent_app_number] => 12452264 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452264
IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS Jun 24, 2008 Abandoned
Array ( [id] => 4852498 [patent_doc_number] => 20080318241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Methods and Systems for Detecting Antiangiogenesis' [patent_app_type] => utility [patent_app_number] => 12/140778 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8744 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318241.pdf [firstpage_image] =>[orig_patent_app_number] => 12140778 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/140778
Methods and Systems for Detecting Antiangiogenesis Jun 16, 2008 Abandoned
Array ( [id] => 6070157 [patent_doc_number] => 20110045007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE' [patent_app_type] => utility [patent_app_number] => 12/602416 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48160 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045007.pdf [firstpage_image] =>[orig_patent_app_number] => 12602416 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/602416
FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE May 29, 2008 Abandoned
Array ( [id] => 5495810 [patent_doc_number] => 20090263838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer' [patent_app_type] => utility [patent_app_number] => 12/155148 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6588 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263838.pdf [firstpage_image] =>[orig_patent_app_number] => 12155148 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/155148
Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer May 29, 2008 Abandoned
Array ( [id] => 4697774 [patent_doc_number] => 20080219958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'METHOD FOR INDUCING AN ANTI-TUMOR AND ANTI-CACHEXIA IMMUNE RESPONSE IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/126744 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5853 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219958.pdf [firstpage_image] =>[orig_patent_app_number] => 12126744 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/126744
Method for inducing an anti-tumor and anti-cachexia immune response in mammals May 22, 2008 Issued
Array ( [id] => 5440914 [patent_doc_number] => 20090092553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 12/122574 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13582 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092553.pdf [firstpage_image] =>[orig_patent_app_number] => 12122574 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/122574
MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS May 15, 2008 Abandoned
Array ( [id] => 5342822 [patent_doc_number] => 20090181472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'LABELED MOLECULE FOR PROGNOSING TUMOR GRADE OF HEAD NECK CANCER AND METHOD FOR THE SAME' [patent_app_type] => utility [patent_app_number] => 12/117001 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1164 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181472.pdf [firstpage_image] =>[orig_patent_app_number] => 12117001 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/117001
LABELED MOLECULE FOR PROGNOSING TUMOR GRADE OF HEAD NECK CANCER AND METHOD FOR THE SAME May 7, 2008 Abandoned
Array ( [id] => 4960045 [patent_doc_number] => 20080274470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/114584 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3897 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274470.pdf [firstpage_image] =>[orig_patent_app_number] => 12114584 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/114584
NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER May 1, 2008 Abandoned
Array ( [id] => 5289925 [patent_doc_number] => 20090022655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Nanotubes for Cancer Therapy and Diagnostics' [patent_app_type] => utility [patent_app_number] => 12/112986 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022655.pdf [firstpage_image] =>[orig_patent_app_number] => 12112986 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/112986
Nanotubes for cancer therapy and diagnostics Apr 29, 2008 Issued
Array ( [id] => 4739476 [patent_doc_number] => 20080233129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Ligand that has binding specificity for IL-4 and/or lL-13' [patent_app_type] => utility [patent_app_number] => 12/150487 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50160 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233129.pdf [firstpage_image] =>[orig_patent_app_number] => 12150487 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150487
Ligand that has binding specificity for IL-4 and/or lL-13 Apr 28, 2008 Abandoned
Array ( [id] => 4739477 [patent_doc_number] => 20080233130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Ligand that has binding specificity for IL-4 and/or IL-13' [patent_app_type] => utility [patent_app_number] => 12/150567 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50095 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233130.pdf [firstpage_image] =>[orig_patent_app_number] => 12150567 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150567
Ligand that has binding specificity for IL-4 and/or IL-13 Apr 28, 2008 Abandoned
Array ( [id] => 5322874 [patent_doc_number] => 20090060864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies' [patent_app_type] => utility [patent_app_number] => 12/148629 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060864.pdf [firstpage_image] =>[orig_patent_app_number] => 12148629 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/148629
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Apr 20, 2008 Issued
Array ( [id] => 5458226 [patent_doc_number] => 20090258378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'STRESS-INDUCED PHOSPHOPROTEIN 1 AS A BIOMARKER FOR THE DETECTION OF HUMAN OVARIAN CANCERS AND ENDOMETRIOSIS' [patent_app_type] => utility [patent_app_number] => 12/102807 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8355 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258378.pdf [firstpage_image] =>[orig_patent_app_number] => 12102807 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102807
Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis Apr 13, 2008 Issued
Array ( [id] => 177700 [patent_doc_number] => 07655408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues' [patent_app_type] => utility [patent_app_number] => 12/098577 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13313 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655408.pdf [firstpage_image] =>[orig_patent_app_number] => 12098577 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/098577
PCA3 messenger RNA species in benign and malignant prostate tissues Apr 6, 2008 Issued
Array ( [id] => 4683161 [patent_doc_number] => 20080249387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Enhanced monitor compliance' [patent_app_type] => utility [patent_app_number] => 12/080318 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4097 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249387.pdf [firstpage_image] =>[orig_patent_app_number] => 12080318 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/080318
Enhanced monitor compliance Apr 1, 2008 Abandoned
Array ( [id] => 4561088 [patent_doc_number] => 07846447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction' [patent_app_type] => utility [patent_app_number] => 12/077508 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7461 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846447.pdf [firstpage_image] =>[orig_patent_app_number] => 12077508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/077508
Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction Mar 18, 2008 Issued
Array ( [id] => 4727235 [patent_doc_number] => 20080206777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors' [patent_app_type] => utility [patent_app_number] => 12/072651 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206777.pdf [firstpage_image] =>[orig_patent_app_number] => 12072651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/072651
Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors Feb 26, 2008 Abandoned
Array ( [id] => 4718542 [patent_doc_number] => 20080241064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/036875 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26583 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241064.pdf [firstpage_image] =>[orig_patent_app_number] => 12036875 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036875
COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN Feb 24, 2008 Abandoned
Array ( [id] => 4676152 [patent_doc_number] => 20080213782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'SOCS-1 Gene Methylation in Cancer' [patent_app_type] => utility [patent_app_number] => 12/036182 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213782.pdf [firstpage_image] =>[orig_patent_app_number] => 12036182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036182
SOCS-1 gene methylation in cancer Feb 21, 2008 Issued
Menu